Abstract: The invention relates to a device which is used to transfer a medicament from a bottle to an infusion bag or a hypodermic syringe and which comprises a tubular chamber (1). According to the invention, one end of the chamber is open (2) such that the bottle can be inserted therein, while the other end is closed by means of a divider (3) bearing a hollow needle (5). The inventive device completely covers the bottle during the use thereof. In addition, the upper part of the aforementioned chamber (1) is equipped with spring tabs (7) having a free end (8) which is directed towards the interior of the chamber. The device also comprises connection means, e.g. of the female luer lock (9) or male luer lock type.

Abstract: The invention relates to a perforable cap pre-mounted on the end (D) of the double-tipped needle of a safety packaging device for a bottle for medical use. This cap is slidingly mounted in a sealed manner so as to prevent an aerosol effect when the stopper of the bottle or, for example, the injection site of a perfusion bag is perforated.

Abstract: A new family of compounds having anti-inflammatory, anti-viral, and brocho-dilating activity having the following linear and cyclic formulas: ##STR1## and compositions of these, which alone, and in combination with reverse transcriptase inhibitors thereby resulting in an additive or synergistic effect, are useful in inhibiting or suppressing viruses including those exhibiting retroviral replication, or in treating viruses including a retrovirus such as HIV in a human cell population and methods of using these compositions, compounds, and salts thereof.

Abstract: Beta-hydroxamate D-aspartic acid as a medicine, in particular for treating infectious diseases caused by retroviruses, especially those that cause AIDS, as well as for treating tumors.

Abstract: This process for the preparation of products of general formula (I): ##STR1## wherein either R.sub.1 and R.sub.2, which are identical, represent a --CHRR.sub.3 group, in which R and R.sub.3, which are identical or different, represent an alkyl, alkenyl or aralkyl group, or R.sub.1 and R.sub.2, which are identical, represent a --CH.sub.2 R group, in which R represents a hydrogen atom, an alkyl, alkenyl or aralkyl radical, or R.sub.1 and R.sub.2 together form a --CH.sub.2 --(CRR).sub.n --CHR-- radical, in which n represents 0 or 1 and R retains the meaning given previously, is characterized by reacting glyoxal in the presence of an acid catalyst with an excess of the corresponding alcohol of general formula (II) RR.sub.3 CHOH, (III) RCH.sub.2 OH or (IV) --(CRR).sub.n --CHROH, in which R, R.sub.3 and n retain the meaning given previously, then stopping the reaction as soon as the concentration of the desired monoacetal of general formula (I) decreases in the reaction medium in favor of bisacetal.